Olayinka O Ogunleye
Overview
Explore the profile of Olayinka O Ogunleye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wander K, Ogunleye O, Nwagu E, Unigwe U, Odo A, Chukwubike C, et al.
Evol Med Public Health
. 2025 Jan;
12(1):287-297.
PMID: 39759428
Background And Objectives: The optimal iron hypothesis (OIH) posits that risk for infection is lowest at a mild level of iron deficiency. The extent to which this protection results from...
2.
Sono T, Yeika E, Cook A, Kalungia A, Opanga S, Efui Acolatse J, et al.
Expert Rev Anti Infect Ther
. 2023 Sep;
21(10):1025-1055.
PMID: 37740561
Introduction: Antimicrobial resistance (AMR) is a global concern. Currently, the greatest mortality due to AMR is in Africa. A key driver continues to be high levels of dispensing of antibiotics...
3.
Mudenda S, Meyer J, Fadare J, Ogunleye O, Saleem Z, Matafwali S, et al.
PLOS Glob Public Health
. 2023 Sep;
3(9):e0002385.
PMID: 37729153
Adolescents and youths are a key part of the population that needs to be protected against the coronavirus disease 2019 (COVID-19). This is because they are more likely to spread...
4.
Siachalinga L, Godman B, Mwita J, Sefah I, Ogunleye O, Massele A, et al.
Infect Drug Resist
. 2023 Apr;
16:2179-2190.
PMID: 37077250
Background: The rapid rise in antimicrobial resistance (AMR) globally, impacting on morbidity, mortality and costs with sub-Saharan African countries reporting the greatest burden is a concern. Instigation of antimicrobial stewardship...
5.
Mudenda S, Mukosha M, Godman B, Fadare J, Ogunleye O, Meyer J, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560551
The coronavirus disease 2019 (COVID-19) pandemic resulted in the closure of schools to slow the spread of the virus across populations, and the administration of vaccines to protect people from...
6.
Saleem Z, Godman B, Cook A, Khan M, Campbell S, Seaton R, et al.
Antibiotics (Basel)
. 2022 Dec;
11(12).
PMID: 36551481
There are serious concerns with rising antimicrobial resistance (AMR) across countries increasing morbidity, mortality and costs. These concerns have resulted in a plethora of initiatives globally and nationally including national...
7.
Ogunleye O, Godman B, Fadare J, Mudenda S, Adeoti A, Yinka-Ogunleye A, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146631
The introduction of effective vaccines in December 2020 marked a significant step forward in the global response to COVID-19. Given concerns with access, acceptability, and hesitancy across Africa, there is...
8.
Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia A, Tiroyakgosi C, et al.
Expert Opin Drug Saf
. 2022 Jul;
21(8):1089-1111.
PMID: 35876080
Introduction: Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international,...
9.
Etando A, Amu A, Haque M, Schellack N, Kurdi A, Alrasheedy A, et al.
Healthcare (Basel)
. 2021 Dec;
9(12).
PMID: 34946448
Background: Multiple measures introduced early to restrict COVID-19 have dramatically impacted the teaching of medical and pharmacy students, exacerbated by the lack of infrastructure and experience with e-learning at the...
10.
Haque M, Rabiu Abubakar A, Ogunleye O, Sani I, Sefah I, Kurdi A, et al.
J Res Pharm Pract
. 2021 Jul;
10(1):17-22.
PMID: 34295848
Objective: Measures are ongoing to prevent the spread of COVID-19 and treat it with medicines and personal protective equipment (PPE). However, there has been considerable controversy surrounding treatments such as...